 Connection
Jens Kuhn to Virus Diseases
This is a "connection" page, showing publications Jens Kuhn has written about Virus Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.674 |
|
|
|
-
Logue J, Crozier I, Jahrling PB, Kuhn JH. Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections. Expert Rev Vaccines. 2020 01; 19(1):85-103.
Score: 0.520
-
Lackemeyer MG, Kok-Mercado Fd, Wada J, Bollinger L, Kindrachuk J, Wahl-Jensen V, Kuhn JH, Jahrling PB. ABSL-4 aerobiology biosafety and technology at the NIH/NIAID integrated research facility at Fort Detrick. Viruses. 2014 Jan 07; 6(1):137-50.
Score: 0.085
-
Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, Longobardi LE, Boltz D, Kuhn JH, Elledge SJ, Bavari S, Denison MR, Choe H, Farzan M. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 2011 Jan 06; 7(1):e1001258.
Score: 0.069
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|